SILENCE THER. (SLN)

 

Latest News

Results of AGM

RNS Number: 8210L Silence Therapeutics PLC 24 April 2018 Results of AGM London, 24 th April 2018 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that at its Annual General Meeting held on M...

Additional Listing

RNS Number: 5183L Silence Therapeutics PLC 19 April 2018 Additional listing 19 April 2018 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that it has issued and allotted 48,309 new ordinary shares...

Broker Forecast - Peel Hunt issues a broker note on Silence Therapeutics PLC

Peel Hunt today reaffirms its buy investment rating on Silence Therapeutics PLC (LON:SLN) and set its price target at 277...

Silence Therapeutics brings patent infringement proceedings in Portugal

Silence Therapeutics said it had brought patent infringement proceedings in Portugal against Alnylam Pharmaceuticals's P...

All News

DateHeadlineSource
24-04-18Results of AGMRNS
19-04-18Additional ListingRNS
04-04-18Broker Forecast - Peel Hunt issues a broker note on Silence Therapeutics PLCStockMarketWire
03-04-18Silence Therapeutics brings patent infringement proceedings in PortugalStockMarketWire
03-04-18Litigation Update (Portugal and US)RNS
26-03-18Silence to Present at Scientific ConferencesRNS
07-03-18Notice of AGMRNS
06-03-18Broker Forecast - Peel Hunt issues a broker note on Silence Therapeutics PLCStockMarketWire
06-03-18Silence Therapeutics losses narrow after Arrowhead Pharmaceuticals saleStockMarketWire
06-03-18Preliminary results year ended 31 December 2017RNS
05-03-18Silence to present at Cowen Health Care ConferenceRNS
22-02-18Holding(s) in CompanyRNS
20-02-18Notice of ResultsRNS
15-02-18Additional ListingRNS
02-02-18Grant of share options and restricted stock unitsRNS
02-02-18Holding(s) in CompanyRNS
31-01-18Holding(s) in CompanyRNS
22-01-18Silence Therapeutics granted European patentStockMarketWire
22-01-18Key European patent grantedRNS
08-01-18Post year end business updateRNS
28-12-17Silence Therapeutics sells more shares in ArrowheadStockMarketWire
28-12-17Further Partial Disposal - Arrowhead common sharesRNS
15-12-17Second Price Monitoring ExtnRNS
15-12-17Price Monitoring ExtensionRNS
14-12-17Price Monitoring ExtensionRNS
14-12-17Broker Forecast - Peel Hunt issues a broker note on Silence Therapeutics PLCStockMarketWire
11-12-17Further Partial Disposal - Arrowhead common sharesRNS
04-12-17Silence Therapeutics sells some Arrowhead sharesStockMarketWire
04-12-17Partial Disposal of Arrowhead common sharesRNS
20-11-17Silence Therapeutics provides litigation updateStockMarketWire
20-11-17Update on litigation mattersRNS
14-11-17Capital Markets DayRNS
03-11-17Silence Therapeutics provides litigation updateStockMarketWire
03-11-17Update on Litigation MattersRNS
02-11-17Second Price Monitoring ExtnRNS
02-11-17Price Monitoring ExtensionRNS
26-10-17Holding(s) in CompanyRNS
24-10-17Holding(s) in CompanyRNS
19-10-17Holding(s) in CompanyRNS
18-10-17Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:SLN Editorial
  • Regulatory news feed for LSE:SLN Regulatory